Surendra Babu Gudapati, MD
Cardiovascular Disease (Cardiology) · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 31
- 8 carriers
- Office
- 1
Offices
1 location · Valley Medical Consultants Inc · 5 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
31 plans · 8 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Gudapati’s office at (650) 962-4410 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
31 of 31 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A76026 · Current
Licensed to practise in California · since 2001 · expires 2027-07-31 · Osmania University, Osmania Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$257,397
Medicare paid this office $257,397 for 1,189 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 550 | $95,649 | $108 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 190 | $38,223 | $198 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 38 | $17,784 | $468 |
| New patient visit (45+ min) | 129 | $17,027 | $132 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 62 | $13,516 | $218 |
See all 20 services
| Return visit (30+ min) | 550 | $95,649 | $108 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 190 | $38,223 | $198 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 38 | $17,784 | $468 |
| New patient visit (45+ min) | 129 | $17,027 | $132 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 62 | $13,516 | $218 |
| Short return visit (20+ min) | 120 | $10,994 | $85 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 65 | $8,706 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 47 | $8,261 | $72 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 123 | $7,946 | $61 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 14 | $6,730 | $481 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 38 | $5,958 | $78 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 40 | $3,650 | $47 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 16 | $3,150 | $197 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 396 | $2,846 | $6 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 223 | $2,790 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 38 | $2,444 | $64 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 75 | $1,737 | $23 |
| New patient visit (30+ min) | 13 | $1,191 | $92 |
| Heart rhythm recording of continous external ekg over 8-15 days | 78 | $979 | $13 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 16 | $327 | None |
Procedures Medicare counted
| Coronary angioplasty and stenting | 1-10 | None |
| Pacemaker insertion or repair | 1-10 | None |
Who their Medicare patients are
1,189 Original Medicare patients in 2024. Average age 79 · Under 65 3% · 85 and older 29% · Women 49% · Also on Medicaid 17% · Health risk score 1.59. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 44% · Diabetes 37% · Atrial fibrillation 33% · Chronic kidney disease 30% · Heart failure 27% · Cancer 19% · Depression 19% · COPD 16% · Dementia 15% · Stroke 15%.
The office billed $1,013,712, Medicare allowed $356,960 and paid $257,397; for 3,746 services of 45 kinds; $381 of it was for drugs given in the office and $257,016 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,189 | 3,746 | 79 | 1.59 | $1,013,712 | $257,397 |
| 2023 | 1,179 | 4,362 | 79 | 1.75 | $1,135,978 | $307,004 |
| 2022 | 1,263 | 5,128 | 78 | 1.69 | $1,157,666 | $351,620 |
| 2021 | 1,210 | 5,344 | 78 | 1.75 | $888,941 | $333,473 |
| 2020 | 1,179 | 4,557 | 78 | 1.93 | $777,896 | $288,958 |
| 2019 | 1,385 | 5,818 | 78 | 1.93 | $790,445 | $350,364 |
| 2018 | 1,232 | 5,504 | 78 | 1.95 | $724,007 | $324,492 |
| 2017 | 1,229 | 5,011 | 78 | 2.00 | $706,089 | $407,224 |
| 2016 | 1,106 | 4,626 | 78 | 1.96 | $585,448 | $292,082 |
| 2015 | 1,175 | 5,018 | 79 | 1.92 | $650,458 | $306,778 |
| 2014 | 711 | 4,177 | 78 | 2.01 | $520,449 | $261,956 |
| 2013 | 761 | 1,989 | 78 | 2.02 | $339,341 | $151,270 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 20 services
| Return visit (30+ min) | 518 | $106,289 | $109 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 176 | $36,344 | $199 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 50 | $23,777 | $476 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 279 | $18,620 | $63 |
| New patient visit (45+ min) | 112 | $15,695 | $140 |
| Short return visit (20+ min) | 162 | $15,487 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 81 | $14,714 | $73 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 57 | $13,292 | $233 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 76 | $10,567 | $119 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 50 | $7,937 | $80 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 40 | $7,035 | $160 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $5,595 | $110 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 44 | $4,576 | $52 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 51 | $3,220 | $63 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 319 | $2,713 | $6 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 176 | $2,407 | $12 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 11 | $2,252 | $205 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 70 | $1,627 | $23 |
| Heart rhythm recording of continous external ekg over 8-15 days | 69 | $805 | $11 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 23 | $394 | None |
2022: 23 services
| Return visit (30+ min) | 557 | $126,431 | $111 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 146 | $30,247 | $200 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 340 | $22,637 | $63 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 44 | $21,261 | $483 |
| New patient visit (45+ min) | 142 | $20,376 | $143 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 44 | $18,506 | $210 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 104 | $17,135 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 104 | $14,347 | $124 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 65 | $12,748 | $182 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 42 | $10,193 | $243 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 18 | $10,174 | $484 |
| Short return visit (20+ min) | 83 | $7,713 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 59 | $6,974 | $94 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 47 | $4,733 | $51 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 22 | $4,325 | $197 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 206 | $2,867 | $13 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 44 | $2,786 | $63 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 298 | $2,759 | $7 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 60 | $1,508 | $24 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 14 | $1,067 | $76 |
| Heart rhythm recording of continous external ekg over 8-15 days | 65 | $985 | $15 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 32 | $544 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $172 | $12 |
2021: 24 services
| Return visit (30+ min) | 495 | $107,036 | $110 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 54 | $28,114 | $521 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 380 | $27,426 | $65 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 119 | $25,435 | $207 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 125 | $24,229 | $186 |
| New patient visit (45+ min) | 119 | $17,508 | $147 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 122 | $16,851 | $67 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 95 | $12,521 | $125 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 55 | $11,387 | $104 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 19 | $10,344 | $493 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 72 | $9,148 | $95 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 38 | $9,075 | $239 |
| Short return visit (20+ min) | 51 | $4,721 | $91 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 47 | $4,508 | $50 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 20 | $4,043 | $202 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 54 | $3,439 | $64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 273 | $2,709 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 165 | $2,258 | $13 |
| Ultrasound of heart with probe in esophagus, with report | 12 | $1,221 | $102 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 44 | $1,102 | $24 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 13 | $974 | $75 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 43 | $865 | None |
| Heart rhythm recording of continous external ekg over 8-15 days | 53 | $834 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 18 | $244 | $14 |
2020: 24 services
| Return visit (30+ min) | 464 | $85,499 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 404 | $29,304 | $68 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 111 | $24,610 | $210 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 108 | $21,422 | $188 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 35 | $17,674 | $505 |
| New patient visit (45+ min) | 99 | $14,576 | $147 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 86 | $14,091 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 78 | $9,921 | $67 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 38 | $9,371 | $247 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 67 | $8,725 | $126 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 15 | $8,431 | $496 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 35 | $6,725 | $96 |
| Short return visit (20+ min) | 94 | $6,715 | $63 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 25 | $5,050 | $202 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 50 | $3,434 | $39 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 278 | $2,807 | $8 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 36 | $2,284 | $63 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 130 | $2,090 | $15 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 14 | $1,616 | $56 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 17 | $1,467 | $86 |
| External ekg recording for more than 48 hours up to 21 days | 36 | $915 | $25 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 36 | $898 | $24 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 31 | $594 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 13 | $180 | $14 |
2019: 28 services
| Return visit (30+ min) | 454 | $83,859 | $92 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 484 | $34,790 | $66 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 121 | $25,254 | $207 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 129 | $24,977 | $180 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 48 | $24,075 | $502 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 110 | $17,600 | $93 |
| Short return visit (20+ min) | 188 | $16,976 | $66 |
| New patient visit (45+ min) | 111 | $16,190 | $146 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 123 | $15,700 | $119 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 103 | $12,954 | $65 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 48 | $9,175 | $96 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 15 | $9,147 | $457 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 32 | $7,330 | $229 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 21 | $4,294 | $204 |
| Initial hospital observation care per day, typically 70 minutes | 21 | $3,492 | $166 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 377 | $3,485 | $8 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 52 | $3,281 | $62 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 49 | $3,253 | $38 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 143 | $2,499 | $16 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 24 | $2,273 | $84 |
| Programming of multiple lead implantable defibrillator system | 11 | $1,803 | $78 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 13 | $1,578 | $19 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 42 | $1,041 | $24 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 40 | $963 | None |
| External ekg recording for more than 48 hours up to 21 days | 35 | $942 | $27 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 46 | $613 | $13 |
| Blood test, clotting time | 14 | $415 | $4 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 13 | $407 | $8 |
2018: 27 services
| Return visit (30+ min) | 413 | $83,085 | $92 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 453 | $30,967 | $64 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 120 | $24,983 | $205 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 129 | $24,916 | $175 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 119 | $22,430 | $91 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 41 | $20,448 | $499 |
| New patient visit (45+ min) | 116 | $15,689 | $135 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 109 | $15,599 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 112 | $14,105 | $119 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 41 | $9,340 | $228 |
| Short return visit (20+ min) | 113 | $8,204 | $62 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 41 | $7,448 | $91 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 25 | $4,845 | $194 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 48 | $2,910 | $61 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 298 | $2,653 | $7 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 26 | $2,219 | $82 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 105 | $1,778 | $16 |
| Programming of multiple lead implantable defibrillator system | 12 | $1,726 | $78 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 34 | $1,712 | $34 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 16 | $1,597 | $20 |
| External ekg recording for more than 48 hours up to 21 days | 44 | $1,185 | $27 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 46 | $1,165 | $24 |
| Ultrasound of heart with probe in esophagus, with report | 11 | $1,054 | $96 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 39 | $975 | None |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 18 | $587 | $8 |
| Blood test, clotting time | 22 | $527 | $5 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 21 | $274 | $13 |
2017: 25 services
| Return visit (30+ min) | 346 | $95,869 | $121 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 173 | $44,303 | $234 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 511 | $41,331 | $75 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 133 | $36,478 | $122 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 87 | $26,227 | $298 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 37 | $23,681 | $640 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 100 | $19,681 | $85 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 83 | $14,223 | $158 |
| New patient visit (45+ min) | 72 | $13,614 | $189 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 19 | $12,426 | $654 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 28 | $9,555 | $341 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 37 | $8,878 | $120 |
| Short return visit (20+ min) | 79 | $7,806 | $74 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 27 | $6,764 | $251 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 40 | $3,471 | $83 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 350 | $3,321 | $7 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 34 | $2,744 | $44 |
| Ultrasound of heart with probe in esophagus, with report | 15 | $1,938 | $129 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 17 | $1,861 | $109 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 73 | $1,636 | $21 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 13 | $1,601 | $22 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 30 | $607 | None |
| Blood test, clotting time | 18 | $544 | $5 |
| External ekg recording for more than 48 hours up to 21 days | 19 | $508 | $27 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 28 | $377 | $13 |
2016: 27 services
| Return visit (30+ min) | 318 | $64,703 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 211 | $42,810 | $179 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 427 | $26,817 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 106 | $20,370 | $93 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 40 | $20,219 | $505 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 71 | $16,473 | $226 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 111 | $15,368 | $64 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 33 | $9,018 | $273 |
| New patient visit (45+ min) | 61 | $8,723 | $143 |
| Short return visit (20+ min) | 99 | $8,140 | $61 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 40 | $7,370 | $93 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 48 | $5,832 | $119 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 22 | $4,829 | $210 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 23 | $3,444 | $150 |
| Initial hospital observation care per day, typically 70 minutes | 16 | $2,974 | $165 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 42 | $2,724 | $65 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 278 | $2,356 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 87 | $1,460 | $16 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 26 | $1,287 | $32 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 17 | $1,250 | $74 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 17 | $1,079 | $17 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 13 | $948 | $59 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 30 | $760 | None |
| Programming of dual lead pacemaker system | 13 | $635 | $45 |
| Blood test, clotting time | 24 | $593 | $5 |
| External ekg recording for more than 48 hours up to 21 days | 12 | $337 | $28 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 11 | $265 | $24 |
2015: 28 services
| Return visit (30+ min) | 301 | $56,154 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 162 | $31,532 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 139 | $27,319 | $181 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 350 | $21,753 | $57 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 84 | $19,419 | $226 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 37 | $18,652 | $504 |
| Short return visit (20+ min) | 191 | $17,288 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 129 | $16,903 | $122 |
| New patient visit (45+ min) | 82 | $11,855 | $145 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 36 | $9,817 | $273 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 37 | $9,776 | $132 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 56 | $7,720 | $93 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 32 | $7,040 | $220 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 12 | $5,823 | $485 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 423 | $4,007 | $8 |
| Ultrasound of both sides of head and neck blood flow | 19 | $3,964 | $209 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 42 | $2,769 | $66 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 30 | $1,977 | $17 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 112 | $1,876 | $16 |
| Initial hospital observation care per day, typically 70 minutes | 11 | $1,829 | $166 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 18 | $1,621 | $85 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 29 | $1,422 | $34 |
| Ultrasound of heart with probe in esophagus, with report | 12 | $1,311 | $109 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 18 | $1,285 | $71 |
| Blood test, clotting time | 44 | $1,153 | $5 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 29 | $802 | None |
| Programming of dual lead pacemaker system | 12 | $725 | $56 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 25 | $327 | $13 |
2014: 22 services
| Return visit (30+ min) | 275 | $51,532 | $90 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 89 | $20,483 | $228 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 38 | $18,917 | $498 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 312 | $18,837 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 127 | $17,229 | $64 |
| Short return visit (20+ min) | 177 | $17,148 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 86 | $15,649 | $180 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 111 | $14,362 | $122 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 39 | $10,152 | $132 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 33 | $9,274 | $281 |
| New patient visit (45+ min) | 60 | $8,853 | $148 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 59 | $8,087 | $92 |
| Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) | 33 | $2,762 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 41 | $2,708 | $64 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 33 | $2,411 | $17 |
| Ultrasound of both sides of head and neck blood flow | 13 | $2,276 | $175 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 119 | $2,075 | $15 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 30 | $1,637 | $33 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 18 | $1,444 | $80 |
| Programming of dual lead pacemaker system | 20 | $1,397 | $52 |
| Ultrasound of heart with probe in esophagus, with report | 12 | $1,220 | $94 |
| Blood test, clotting time | 33 | $1,210 | $5 |
2013: 23 services
| Return visit (30+ min) | 177 | $22,963 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 98 | $15,145 | $62 |
| Short return visit (20+ min) | 157 | $13,719 | $67 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 196 | $11,554 | $55 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $11,164 | $174 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 62 | $7,572 | $118 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 39 | $7,353 | $189 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 13 | $7,279 | $455 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 13 | $6,671 | $513 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 25 | $5,517 | $221 |
| New patient visit (45+ min) | 36 | $5,275 | $147 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 13 | $3,428 | $132 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $3,040 | $89 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 270 | $2,519 | $7 |
| Injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270) | 13 | $2,230 | None |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 15 | $1,215 | $81 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 61 | $1,147 | $17 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 24 | $1,116 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 16 | $1,093 | $68 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 24 | $878 | $35 |
| Blood test, clotting time | 29 | $376 | $5 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $180 | $13 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 17 | $150 | $6 |
Medicaid work
$1,486 in 2024
Medicaid paid $1,486 for 277 billed services this clinician did in 2024, up to 125 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 265 | $1,240 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 12 | $245 |
| 2024 | 277 | 2 | 125 | $1,486 |
| 2023 | 451 | 3 | 96 | $4,081 |
| 2022 | 414 | 3 | 96 | $3,091 |
| 2021 | 361 | 3 | 60 | $2,902 |
| 2020 | 322 | 3 | 59 | $2,648 |
| 2019 | 232 | 2 | 61 | $2,040 |
| 2018 | 172 | 2 | 61 | $1,478 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 182 | $2,551 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 224 | $1,059 |
| Return visit (30+ min) | 45 | $471 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 143 | $2,096 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 191 | $900 |
| Return visit (30+ min) | 80 | $95 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 206 | $2,077 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 129 | $585 |
| Return visit (30+ min) | 26 | $240 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 171 | $1,957 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 136 | $691 |
| Return visit (30+ min) | 15 | $0 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 69 | $1,329 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 163 | $711 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 133 | $770 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 39 | $708 |
Drugs they prescribed that Part D paid
$1,041,019
Pharmacies billed $1,041,019 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
5,008 generic and fewer than 11 brand-name prescriptions · $1,041,019 in drug cost · 20 antibiotic prescriptions to 17 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 366 | $529,853 | $1,448 |
| Xarelto | 72 | $108,626 | $1,509 |
| Entresto | 77 | $86,625 | $1,125 |
| Farxiga | 61 | $69,251 | $1,135 |
| Jardiance | 42 | $48,645 | $1,158 |
See all 59 drugs
| Eliquis | 366 | $529,853 | $1,448 |
| Xarelto | 72 | $108,626 | $1,509 |
| Entresto | 77 | $86,625 | $1,125 |
| Farxiga | 61 | $69,251 | $1,135 |
| Jardiance | 42 | $48,645 | $1,158 |
| Januvia | 17 | $25,994 | $1,529 |
| Ozempic | 18 | $16,415 | $912 |
| Nexletol | 13 | $15,995 | $1,230 |
| Praluent | 18 | $15,130 | $841 |
| Ezetimibe | 304 | $12,194 | $40 |
| Atorvastatin | 778 | $7,687 | $10 |
| Metoprolol | 358 | $5,619 | $16 |
| Rosuvastatin | 374 | $5,287 | $14 |
| Amiodarone | 59 | $5,098 | $86 |
| Potassium Chloride | 84 | $4,812 | $57 |
| Diltiazem 24hr Er (Cd) | 96 | $4,278 | $45 |
| Losartan | 421 | $3,633 | $9 |
| Digoxin | 91 | $3,374 | $37 |
| Valsartan | 116 | $3,355 | $29 |
| Amlodipine Besylate | 430 | $2,836 | $7 |
| Clopidogrel | 175 | $2,197 | $13 |
| Carvedilol | 194 | $1,979 | $10 |
| Flecainide Acetate | 35 | $1,960 | $56 |
| Losartan-Hydrochlorothiazide | 74 | $1,767 | $24 |
| Isosorbide Dinitrate | 21 | $1,326 | $63 |
| Spironolactone | 76 | $1,018 | $13 |
| Furosemide | 189 | $961 | $5 |
| Nifedipine Er | 28 | $913 | $33 |
| Amlodipine-Valsartan | 11 | $876 | $80 |
| Propranolol Hcl Er | 15 | $858 | $57 |
| Metoprolol | 68 | $829 | $12 |
| Doxazosin Mesylate | 47 | $787 | $17 |
| Hydrochlorothiazide | 96 | $658 | $7 |
| Lisinopril | 73 | $656 | $9 |
| Bumetanide | 22 | $645 | $29 |
| Pantoprazole | 36 | $618 | $17 |
| Hydralazine | 45 | $527 | $12 |
| Levothyroxine | 45 | $476 | $11 |
| Metformin Hcl Er | 66 | $465 | $7 |
| Isosorbide Mononitrate Er | 30 | $452 | $15 |
| Chlorthalidone | 17 | $417 | $25 |
| Telmisartan | 15 | $406 | $27 |
| Benazepril | 25 | $338 | $14 |
| Nitroglycerin | 38 | $336 | $9 |
| Verapamil Er | 17 | $306 | $18 |
| Propranolol | 24 | $282 | $12 |
| Tamsulosin | 28 | $282 | $10 |
| Ramipril | 30 | $274 | $9 |
| Torsemide | 23 | $201 | $9 |
| Metformin | 41 | $199 | $5 |
| Trazodone | 22 | $175 | $8 |
| Pravastatin | 22 | $173 | $8 |
| Amlodipine Besylate-Benazepril | 13 | $156 | $12 |
| Triamterene-Hydrochlorothiazid | 12 | $145 | $12 |
| Atenolol | 15 | $136 | $9 |
| Allopurinol | 11 | $94 | $9 |
| Simvastatin | 11 | $84 | $8 |
| Warfarin | 16 | $46 | $3 |
| Cephalexin | 12 | $40 | $3 |
Year by year
| 2024 | 5,835 | 724 | None | None | $1,041,019 |
| 2023 | 5,246 | 663 | None | None | $885,795 |
| 2022 | 5,081 | 633 | None | None | $712,210 |
| 2021 | 4,794 | 556 | None | 12% | $577,262 |
| 2020 | 4,405 | 490 | None | None | $488,751 |
| 2019 | 3,803 | 452 | None | None | $378,094 |
| 2018 | 3,020 | 364 | None | 16% | $278,643 |
| 2017 | 2,845 | 309 | None | 18% | $226,196 |
| 2016 | 2,894 | 280 | None | 19% | $214,077 |
| 2015 | 2,704 | 272 | 1% (13) | 21% | $173,082 |
| 2014 | 2,460 | 233 | None | None | $126,609 |
| 2013 | 2,202 | 199 | 1% (18) | 17% | $100,635 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 59 drugs
| Eliquis | 324 | $473,547 | $1,462 |
| Xarelto | 83 | $121,160 | $1,460 |
| Entresto | 29 | $45,678 | $1,575 |
| Farxiga | 29 | $31,744 | $1,095 |
| Januvia | 22 | $27,247 | $1,239 |
| Praluent | 22 | $13,977 | $635 |
| Ezetimibe | 236 | $13,571 | $58 |
| Ozempic | 13 | $13,227 | $1,017 |
| Jardiance | 13 | $12,771 | $982 |
| Nexlizet | 14 | $11,919 | $851 |
| Atorvastatin | 708 | $10,493 | $15 |
| Metoprolol | 339 | $7,491 | $22 |
| Diltiazem 24hr Er (Cd) | 88 | $7,401 | $84 |
| Rosuvastatin | 289 | $5,775 | $20 |
| Losartan | 378 | $5,124 | $14 |
| Potassium Chloride | 89 | $4,818 | $54 |
| Amlodipine Besylate | 413 | $4,578 | $11 |
| Valsartan | 100 | $4,352 | $44 |
| Amiodarone | 41 | $3,837 | $94 |
| Clopidogrel | 175 | $3,332 | $19 |
| Carvedilol | 217 | $3,198 | $15 |
| Digoxin | 77 | $2,748 | $36 |
| Flecainide Acetate | 44 | $2,713 | $62 |
| Losartan-Hydrochlorothiazide | 82 | $2,224 | $27 |
| Nifedipine Er | 25 | $1,942 | $78 |
| Amlodipine-Valsartan | 17 | $1,924 | $113 |
| Isosorbide Dinitrate | 19 | $1,913 | $101 |
| Furosemide | 185 | $1,338 | $7 |
| Pantoprazole | 47 | $1,312 | $28 |
| Doxazosin Mesylate | 51 | $1,282 | $25 |
| Hydralazine | 59 | $1,052 | $18 |
| Bumetanide | 16 | $972 | $61 |
| Propranolol Hcl Er | 11 | $912 | $83 |
| Metoprolol | 61 | $888 | $15 |
| Telmisartan | 13 | $853 | $66 |
| Levothyroxine | 43 | $839 | $20 |
| Verapamil Er | 16 | $823 | $51 |
| Metformin Hcl Er | 46 | $693 | $15 |
| Hydrochlorothiazide | 79 | $657 | $8 |
| Isosorbide Mononitrate Er | 23 | $656 | $29 |
| Spironolactone | 48 | $625 | $13 |
| Chlorthalidone | 18 | $575 | $32 |
| Lisinopril | 69 | $550 | $8 |
| Amlodipine Besylate-Benazepril | 16 | $547 | $34 |
| Valsartan-Hydrochlorothiazide | 15 | $456 | $30 |
| Ramipril | 14 | $447 | $32 |
| Metformin | 40 | $363 | $9 |
| Klor-Con 10 | 13 | $325 | $25 |
| Propranolol | 14 | $312 | $22 |
| Tamsulosin | 15 | $303 | $20 |
| Nitroglycerin | 21 | $296 | $14 |
| Torsemide | 24 | $287 | $12 |
| Triamterene-Hydrochlorothiazid | 16 | $278 | $17 |
| Trazodone | 14 | $273 | $19 |
| Simvastatin | 21 | $266 | $13 |
| Pravastatin | 13 | $228 | $18 |
| Atenolol | 20 | $174 | $9 |
| Warfarin | 16 | $151 | $9 |
| Lisinopril-Hydrochlorothiazide | 15 | $101 | $7 |
2022: 51 drugs
| Eliquis | 260 | $351,019 | $1,350 |
| Xarelto | 105 | $128,636 | $1,225 |
| Januvia | 30 | $37,494 | $1,250 |
| Entresto | 22 | $28,781 | $1,308 |
| Ezetimibe | 218 | $18,275 | $84 |
| Diltiazem 24hr Er (Cd) | 97 | $9,243 | $95 |
| Atorvastatin | 725 | $8,989 | $12 |
| Metoprolol | 334 | $8,227 | $25 |
| Rosuvastatin | 257 | $6,179 | $24 |
| Potassium Chloride | 108 | $5,366 | $50 |
| Digoxin | 74 | $5,001 | $68 |
| Amiodarone | 42 | $4,961 | $118 |
| Nexlizet | 12 | $4,953 | $413 |
| Losartan | 337 | $4,595 | $14 |
| Carvedilol | 293 | $3,930 | $13 |
| Clopidogrel | 177 | $3,589 | $20 |
| Amlodipine Besylate | 407 | $3,578 | $9 |
| Flecainide Acetate | 48 | $3,288 | $69 |
| Valsartan | 78 | $3,171 | $41 |
| Nifedipine Er | 32 | $2,200 | $69 |
| Losartan-Hydrochlorothiazide | 75 | $2,106 | $28 |
| Furosemide | 188 | $1,385 | $7 |
| Lisinopril | 101 | $1,159 | $11 |
| Verapamil Er | 26 | $1,152 | $44 |
| Pantoprazole | 39 | $1,071 | $27 |
| Hydrochlorothiazide | 89 | $1,068 | $12 |
| Hydralazine | 50 | $988 | $20 |
| Chlorthalidone | 30 | $848 | $28 |
| Doxazosin Mesylate | 28 | $809 | $29 |
| Metformin Hcl Er | 59 | $767 | $13 |
| Levothyroxine | 31 | $763 | $25 |
| Propranolol Hcl Er | 11 | $710 | $65 |
| Amlodipine Besylate-Benazepril | 18 | $709 | $39 |
| Isosorbide Mononitrate Er | 26 | $524 | $20 |
| Torsemide | 27 | $475 | $18 |
| Spironolactone-Hctz | 14 | $441 | $31 |
| Metoprolol | 47 | $422 | $9 |
| Valsartan-Hydrochlorothiazide | 11 | $389 | $35 |
| Spironolactone | 35 | $375 | $11 |
| Metformin | 39 | $372 | $10 |
| Triamterene-Hydrochlorothiazid | 20 | $317 | $16 |
| Pravastatin | 14 | $298 | $21 |
| Nitroglycerin | 20 | $298 | $15 |
| Warfarin | 23 | $284 | $12 |
| Simvastatin | 28 | $260 | $9 |
| Ramipril | 17 | $243 | $14 |
| Atenolol | 23 | $225 | $10 |
| Tamsulosin | 17 | $209 | $12 |
| Allopurinol | 11 | $200 | $18 |
| Diltiazem 24hr Er | 12 | $193 | $16 |
| Trazodone | 12 | $164 | $14 |
2021: 49 drugs
| Eliquis | 262 | $296,818 | $1,133 |
| Xarelto | 83 | $87,579 | $1,055 |
| Entresto | 28 | $35,926 | $1,283 |
| Januvia | 12 | $17,878 | $1,490 |
| Ezetimibe | 185 | $10,215 | $55 |
| Atorvastatin | 713 | $10,204 | $14 |
| Diltiazem 24hr Er (Cd) | 74 | $8,848 | $120 |
| Metoprolol | 285 | $7,268 | $26 |
| Digoxin | 88 | $5,483 | $62 |
| Losartan | 378 | $5,289 | $14 |
| Flecainide Acetate | 44 | $4,127 | $94 |
| Carvedilol | 255 | $3,345 | $13 |
| Amlodipine Besylate | 331 | $3,137 | $9 |
| Omega-3 Acid Ethyl Esters | 21 | $3,082 | $147 |
| Rosuvastatin | 152 | $3,054 | $20 |
| Clopidogrel | 156 | $2,727 | $17 |
| Amiodarone | 51 | $2,241 | $44 |
| Valsartan | 57 | $2,124 | $37 |
| Losartan-Hydrochlorothiazide | 50 | $2,116 | $42 |
| Potassium Chloride | 75 | $2,003 | $27 |
| Nifedipine Er | 33 | $1,856 | $56 |
| Hydralazine | 77 | $1,511 | $20 |
| Verapamil Er | 17 | $1,401 | $82 |
| Furosemide | 215 | $1,339 | $6 |
| Chlorthalidone | 33 | $1,241 | $38 |
| Lisinopril | 104 | $1,175 | $11 |
| Hydrochlorothiazide | 83 | $1,051 | $13 |
| Pantoprazole | 43 | $996 | $23 |
| Isosorbide Mononitrate Er | 48 | $907 | $19 |
| Doxazosin Mesylate | 30 | $875 | $29 |
| Propranolol Hcl Er | 15 | $871 | $58 |
| Torsemide | 34 | $697 | $20 |
| Amlodipine Besylate-Benazepril | 13 | $674 | $52 |
| Valsartan-Hydrochlorothiazide | 12 | $610 | $51 |
| Levothyroxine | 26 | $601 | $23 |
| Nitroglycerin | 37 | $581 | $16 |
| Spironolactone | 46 | $481 | $10 |
| Warfarin | 38 | $470 | $12 |
| Metoprolol | 41 | $452 | $11 |
| Metformin Hcl Er | 55 | $383 | $7 |
| Simvastatin | 35 | $343 | $10 |
| Atenolol | 27 | $343 | $13 |
| Triamterene-Hydrochlorothiazid | 20 | $327 | $16 |
| Ramipril | 20 | $322 | $16 |
| Allopurinol | 23 | $317 | $14 |
| Tamsulosin | 19 | $253 | $13 |
| Metformin | 34 | $238 | $7 |
| Terazosin | 13 | $192 | $15 |
| Trazodone | 13 | $38 | $3 |
2020: 51 drugs
| Eliquis | 267 | $259,705 | $973 |
| Xarelto | 76 | $76,217 | $1,003 |
| Ezetimibe | 174 | $12,232 | $70 |
| Metoprolol | 279 | $8,938 | $32 |
| Atorvastatin | 554 | $8,582 | $15 |
| Diltiazem 24hr Er (Cd) | 42 | $6,177 | $147 |
| Digoxin | 112 | $5,992 | $54 |
| Flecainide Acetate | 50 | $5,341 | $107 |
| Losartan | 347 | $5,263 | $15 |
| Potassium Chloride | 99 | $3,694 | $37 |
| Amiodarone | 52 | $3,478 | $67 |
| Losartan-Hydrochlorothiazide | 39 | $3,128 | $80 |
| Clopidogrel | 179 | $3,063 | $17 |
| Rosuvastatin | 81 | $2,781 | $34 |
| Carvedilol | 230 | $2,715 | $12 |
| Omega-3 Acid Ethyl Esters | 15 | $2,550 | $170 |
| Valsartan | 46 | $2,542 | $55 |
| Amlodipine Besylate | 231 | $2,045 | $9 |
| Furosemide | 227 | $1,660 | $7 |
| Synthroid | 25 | $1,651 | $66 |
| Hydralazine | 66 | $1,299 | $20 |
| Isosorbide Mononitrate Er | 74 | $1,259 | $17 |
| Levothyroxine | 51 | $1,235 | $24 |
| Hydrochlorothiazide | 89 | $1,052 | $12 |
| Doxazosin Mesylate | 18 | $955 | $53 |
| Lisinopril | 89 | $952 | $11 |
| Diltiazem 24hr Er | 14 | $908 | $65 |
| Nifedipine Er | 12 | $852 | $71 |
| Labetalol | 13 | $847 | $65 |
| Torsemide | 37 | $817 | $22 |
| Propranolol Hcl Er | 12 | $770 | $64 |
| Warfarin | 50 | $730 | $15 |
| Metformin Hcl Er | 41 | $533 | $13 |
| Simvastatin | 48 | $532 | $11 |
| Spironolactone | 51 | $526 | $10 |
| Ramipril | 28 | $497 | $18 |
| Chlorthalidone | 11 | $480 | $44 |
| Pantoprazole | 31 | $430 | $14 |
| Nitroglycerin | 25 | $353 | $14 |
| Propranolol | 13 | $348 | $27 |
| Atenolol | 22 | $346 | $16 |
| Metoprolol | 42 | $326 | $8 |
| Metformin | 31 | $321 | $10 |
| Allopurinol | 14 | $215 | $15 |
| Triamterene-Hydrochlorothiazid | 16 | $212 | $13 |
| Terazosin | 14 | $194 | $14 |
| Gabapentin | 13 | $175 | $13 |
| Omeprazole | 11 | $157 | $14 |
| Trazodone | 23 | $129 | $6 |
| Clonidine | 13 | $103 | $8 |
| Glimepiride | 11 | $96 | $9 |
2019: 54 drugs
| Eliquis | 203 | $174,760 | $861 |
| Xarelto | 83 | $68,659 | $827 |
| Januvia | 15 | $12,733 | $849 |
| Ezetimibe | 124 | $10,610 | $86 |
| Metoprolol | 249 | $9,417 | $38 |
| Atorvastatin | 479 | $8,364 | $17 |
| Diltiazem 24hr Er (Cd) | 25 | $4,861 | $194 |
| Digoxin | 65 | $4,052 | $62 |
| Flecainide Acetate | 39 | $3,785 | $97 |
| Potassium Chloride | 96 | $3,745 | $39 |
| Losartan | 264 | $3,487 | $13 |
| Clopidogrel | 165 | $3,437 | $21 |
| Carvedilol | 186 | $2,659 | $14 |
| Amlodipine Besylate | 180 | $2,019 | $11 |
| Digox | 31 | $1,817 | $59 |
| Furosemide | 192 | $1,756 | $9 |
| Valsartan | 31 | $1,617 | $52 |
| Amiodarone | 35 | $1,480 | $42 |
| Isosorbide Mononitrate Er | 67 | $1,420 | $21 |
| Synthroid | 25 | $1,389 | $56 |
| Prazosin | 23 | $1,386 | $60 |
| Rosuvastatin | 38 | $1,258 | $33 |
| Hydralazine | 48 | $1,250 | $26 |
| Levothyroxine | 52 | $1,219 | $23 |
| Lisinopril | 83 | $1,202 | $14 |
| Diltiazem 24hr Er | 18 | $1,116 | $62 |
| Nifedipine Er | 14 | $1,095 | $78 |
| Midodrine | 12 | $1,065 | $89 |
| Hydrochlorothiazide | 80 | $963 | $12 |
| Simvastatin | 59 | $911 | $15 |
| Warfarin | 46 | $751 | $16 |
| Digitek | 12 | $746 | $62 |
| Valsartan-Hydrochlorothiazide | 14 | $704 | $50 |
| Losartan-Hydrochlorothiazide | 47 | $688 | $15 |
| Ramipril | 36 | $667 | $19 |
| Diltiazem | 16 | $585 | $37 |
| Spironolactone | 45 | $521 | $12 |
| Pantoprazole | 19 | $498 | $26 |
| Torsemide | 21 | $448 | $21 |
| Metoprolol | 41 | $443 | $11 |
| Doxazosin Mesylate | 13 | $422 | $32 |
| Cartia Xt | 15 | $412 | $27 |
| Clonidine | 12 | $389 | $32 |
| Omeprazole | 11 | $298 | $27 |
| Verapamil Er | 12 | $286 | $24 |
| Metformin Hcl Er | 17 | $286 | $17 |
| Tamsulosin | 12 | $242 | $20 |
| Nitroglycerin | 19 | $233 | $12 |
| Atenolol | 21 | $217 | $10 |
| Metformin | 21 | $208 | $10 |
| Trazodone | 20 | $194 | $10 |
| Allopurinol | 15 | $185 | $12 |
| Terazosin | 14 | $165 | $12 |
| Gabapentin | 21 | $153 | $7 |
2018: 53 drugs
| Xarelto | 101 | $83,675 | $828 |
| Eliquis | 89 | $78,709 | $884 |
| Januvia | 17 | $13,159 | $774 |
| Metoprolol | 178 | $8,120 | $46 |
| Atorvastatin | 377 | $7,612 | $20 |
| Ezetimibe | 47 | $6,250 | $133 |
| Diltiazem 24hr Er (Cd) | 29 | $4,555 | $157 |
| Omega-3 Acid Ethyl Esters | 21 | $3,646 | $174 |
| Digox | 47 | $3,556 | $76 |
| Clopidogrel | 171 | $3,124 | $18 |
| Potassium Chloride | 76 | $2,917 | $38 |
| Pacerone | 11 | $2,210 | $201 |
| Digoxin | 31 | $2,172 | $70 |
| Losartan | 177 | $2,026 | $11 |
| Carvedilol | 147 | $1,764 | $12 |
| Amlodipine Besylate | 160 | $1,600 | $10 |
| Isosorbide Mononitrate Er | 48 | $1,452 | $30 |
| Furosemide | 160 | $1,282 | $8 |
| Diltiazem 24hr Er | 21 | $1,211 | $58 |
| Flecainide Acetate | 19 | $1,169 | $62 |
| Diltiazem 24hr Er (La) | 14 | $1,148 | $82 |
| Levothyroxine | 46 | $1,125 | $24 |
| Synthroid | 20 | $1,124 | $56 |
| Warfarin | 52 | $1,119 | $22 |
| Verapamil Er | 25 | $1,094 | $44 |
| Toprol Xl | 11 | $1,066 | $97 |
| Dilt-Xr | 12 | $1,026 | $86 |
| Lisinopril | 77 | $959 | $12 |
| Rosuvastatin | 23 | $928 | $40 |
| Valsartan | 22 | $912 | $41 |
| Prazosin | 14 | $797 | $57 |
| Pantoprazole | 36 | $751 | $21 |
| Losartan-Hydrochlorothiazide | 48 | $707 | $15 |
| Hydrochlorothiazide | 55 | $636 | $12 |
| Ramipril | 23 | $619 | $27 |
| Simvastatin | 44 | $583 | $13 |
| Hydralazine | 32 | $569 | $18 |
| Pravastatin | 16 | $486 | $30 |
| Valsartan-Hydrochlorothiazide | 11 | $477 | $43 |
| Spironolactone | 33 | $462 | $14 |
| Enalapril Maleate | 11 | $384 | $35 |
| Metformin Hcl Er | 12 | $343 | $29 |
| Atenolol | 30 | $278 | $9 |
| Metoprolol | 31 | $276 | $9 |
| Amiodarone | 27 | $257 | $10 |
| Clonidine | 11 | $229 | $21 |
| Nitroglycerin | 13 | $221 | $17 |
| Metformin | 24 | $217 | $9 |
| Benazepril | 11 | $215 | $20 |
| Tamsulosin | 11 | $191 | $17 |
| Gabapentin | 17 | $132 | $8 |
| Trazodone | 12 | $67 | $6 |
| Cephalexin | 13 | $57 | $4 |
2017: 45 drugs
| Xarelto | 95 | $72,713 | $765 |
| Eliquis | 47 | $36,881 | $785 |
| Metoprolol | 181 | $7,240 | $40 |
| Atorvastatin | 281 | $5,621 | $20 |
| Digox | 82 | $5,372 | $66 |
| Omega-3 Acid Ethyl Esters | 19 | $4,898 | $258 |
| Diltiazem 24hr Er | 40 | $4,555 | $114 |
| Ezetimibe | 15 | $4,499 | $300 |
| Bystolic | 17 | $3,132 | $184 |
| Clopidogrel | 165 | $2,748 | $17 |
| Potassium Chloride | 60 | $2,407 | $40 |
| Digoxin | 37 | $2,228 | $60 |
| Carvedilol | 137 | $1,660 | $12 |
| Losartan | 138 | $1,484 | $11 |
| Warfarin | 70 | $1,357 | $19 |
| Furosemide | 176 | $1,345 | $8 |
| Isosorbide Mononitrate Er | 35 | $1,201 | $34 |
| Valsartan | 30 | $1,159 | $39 |
| Amlodipine Besylate | 165 | $1,099 | $7 |
| Verapamil Er | 24 | $1,054 | $44 |
| Levothyroxine | 31 | $899 | $29 |
| Valsartan-Hydrochlorothiazide | 17 | $799 | $47 |
| Losartan-Hydrochlorothiazide | 71 | $784 | $11 |
| Pravastatin | 35 | $769 | $22 |
| Flecainide Acetate | 13 | $768 | $59 |
| Lisinopril | 66 | $739 | $11 |
| Synthroid | 14 | $655 | $47 |
| Rosuvastatin | 13 | $652 | $50 |
| Hydrochlorothiazide | 50 | $610 | $12 |
| Simvastatin | 68 | $557 | $8 |
| Ramipril | 26 | $548 | $21 |
| Hydralazine | 35 | $540 | $15 |
| Metformin Hcl Er | 15 | $471 | $31 |
| Amiodarone | 34 | $437 | $13 |
| Enalapril Maleate | 21 | $349 | $17 |
| Pantoprazole | 22 | $332 | $15 |
| Prazosin | 11 | $327 | $30 |
| Spironolactone | 33 | $286 | $9 |
| Atenolol | 41 | $269 | $7 |
| Metoprolol | 21 | $173 | $8 |
| Metformin | 21 | $167 | $8 |
| Omeprazole | 21 | $139 | $7 |
| Gabapentin | 16 | $107 | $7 |
| Glimepiride | 11 | $69 | $6 |
| Benazepril | 12 | $62 | $5 |
2016: 49 drugs
| Xarelto | 105 | $67,900 | $647 |
| Eliquis | 42 | $20,439 | $487 |
| Pradaxa | 13 | $7,672 | $590 |
| Vytorin | 16 | $6,528 | $408 |
| Metoprolol | 147 | $5,291 | $36 |
| Atorvastatin | 226 | $4,858 | $21 |
| Potassium Chloride | 82 | $3,367 | $41 |
| Clopidogrel | 154 | $2,677 | $17 |
| Digoxin | 50 | $2,614 | $52 |
| Bystolic | 15 | $2,506 | $167 |
| Digox | 60 | $2,488 | $41 |
| Valsartan | 37 | $2,368 | $64 |
| Metformin Hcl Er | 16 | $2,206 | $138 |
| Carvedilol | 147 | $1,929 | $13 |
| Omega-3 Acid Ethyl Esters | 11 | $1,924 | $175 |
| Diltiazem 24hr Er | 29 | $1,763 | $61 |
| Losartan | 120 | $1,677 | $14 |
| Amlodipine Besylate | 194 | $1,571 | $8 |
| Amiodarone | 54 | $1,385 | $26 |
| Warfarin | 89 | $1,271 | $14 |
| Furosemide | 168 | $1,202 | $7 |
| Pravastatin | 37 | $1,061 | $29 |
| Losartan-Hydrochlorothiazide | 76 | $914 | $12 |
| Isosorbide Mononitrate Er | 45 | $911 | $20 |
| Lisinopril | 82 | $879 | $11 |
| Cartia Xt | 12 | $813 | $68 |
| Metolazone | 12 | $726 | $60 |
| Hydrochlorothiazide | 49 | $647 | $13 |
| Ramipril | 25 | $606 | $24 |
| Taztia Xt | 11 | $569 | $52 |
| Levothyroxine | 20 | $554 | $28 |
| Simvastatin | 77 | $488 | $6 |
| Pantoprazole | 28 | $470 | $17 |
| Prazosin | 12 | $424 | $35 |
| Allopurinol | 32 | $421 | $13 |
| Verapamil Er | 15 | $409 | $27 |
| Hydralazine | 23 | $409 | $18 |
| Metoprolol | 24 | $408 | $17 |
| Atenolol | 44 | $380 | $9 |
| Verapamil Sr | 12 | $315 | $26 |
| Spironolactone | 38 | $243 | $6 |
| Metformin | 22 | $234 | $11 |
| Omeprazole | 26 | $230 | $9 |
| Enalapril Maleate | 23 | $216 | $9 |
| Fludrocortisone Acetate | 12 | $210 | $17 |
| Clonidine | 12 | $180 | $15 |
| Famotidine | 14 | $161 | $11 |
| Benazepril | 28 | $142 | $5 |
| Glimepiride | 18 | $88 | $5 |
2015: 45 drugs
| Xarelto | 105 | $53,959 | $514 |
| Pradaxa | 24 | $12,449 | $519 |
| Eliquis | 25 | $11,056 | $442 |
| Metoprolol | 144 | $5,797 | $40 |
| Atorvastatin | 206 | $4,358 | $21 |
| Metformin Hcl Er | 12 | $3,029 | $252 |
| Digox | 67 | $2,924 | $44 |
| Potassium Chloride | 94 | $2,804 | $30 |
| Clonidine | 11 | $2,541 | $231 |
| Valsartan | 20 | $2,125 | $106 |
| Digoxin | 32 | $2,054 | $64 |
| Clopidogrel | 143 | $1,955 | $14 |
| Warfarin | 111 | $1,835 | $17 |
| Carvedilol | 133 | $1,796 | $14 |
| Amlodipine Besylate | 179 | $1,262 | $7 |
| Pravastatin | 38 | $1,181 | $31 |
| Losartan-Hydrochlorothiazide | 69 | $1,050 | $15 |
| Losartan | 110 | $1,039 | $9 |
| Isosorbide Mononitrate Er | 47 | $893 | $19 |
| Cartia Xt | 15 | $884 | $59 |
| Digitek | 19 | $879 | $46 |
| Taztia Xt | 15 | $748 | $50 |
| Hydrochlorothiazide | 72 | $735 | $10 |
| Furosemide | 138 | $603 | $4 |
| Levothyroxine | 17 | $593 | $35 |
| Ramipril | 22 | $587 | $27 |
| Lisinopril | 79 | $585 | $7 |
| Verapamil Sr | 17 | $531 | $31 |
| Amiodarone | 34 | $500 | $15 |
| Simvastatin | 68 | $435 | $6 |
| Clonidine | 16 | $427 | $27 |
| Allopurinol | 21 | $362 | $17 |
| Metoprolol | 27 | $342 | $13 |
| Atenolol | 38 | $296 | $8 |
| Pantoprazole | 24 | $285 | $12 |
| Verapamil Er | 12 | $250 | $21 |
| Spironolactone | 34 | $222 | $7 |
| Hydralazine | 13 | $195 | $15 |
| Metformin | 24 | $187 | $8 |
| Nitrostat | 12 | $177 | $15 |
| Klor-Con 8 | 15 | $176 | $12 |
| Omeprazole | 12 | $176 | $15 |
| Glimepiride | 17 | $167 | $10 |
| Benazepril | 24 | $125 | $5 |
| Enalapril Maleate | 12 | $21 | $2 |
2014: 49 drugs
| Xarelto | 68 | $33,191 | $488 |
| Diovan | 22 | $10,361 | $471 |
| Metoprolol | 134 | $7,226 | $54 |
| Pradaxa | 11 | $7,151 | $650 |
| Clonidine | 32 | $5,084 | $159 |
| Effient | 12 | $4,655 | $388 |
| Atorvastatin | 194 | $4,626 | $24 |
| Digox | 78 | $4,104 | $53 |
| Carvedilol | 158 | $2,603 | $16 |
| Clopidogrel | 105 | $2,156 | $21 |
| Digoxin | 30 | $1,932 | $64 |
| Amiodarone | 15 | $1,715 | $114 |
| Warfarin | 130 | $1,671 | $13 |
| Pravastatin | 53 | $1,618 | $31 |
| Potassium Chloride | 56 | $1,538 | $27 |
| Losartan | 102 | $1,361 | $13 |
| Amlodipine Besylate | 135 | $1,307 | $10 |
| Losartan-Hydrochlorothiazide | 49 | $1,080 | $22 |
| Cartia Xt | 18 | $979 | $54 |
| Isosorbide Mononitrate Er | 45 | $740 | $16 |
| Hydrochlorothiazide | 70 | $728 | $10 |
| Diltiazem Er | 17 | $592 | $35 |
| Lisinopril | 83 | $580 | $7 |
| Simvastatin | 61 | $565 | $9 |
| Furosemide | 115 | $540 | $5 |
| Tamsulosin | 13 | $491 | $38 |
| Ramipril | 22 | $460 | $21 |
| Clonidine | 17 | $351 | $21 |
| Levothyroxine | 12 | $326 | $27 |
| Klor-Con 10 | 12 | $318 | $27 |
| Omeprazole | 18 | $296 | $16 |
| Spironolactone | 26 | $291 | $11 |
| Atenolol | 33 | $270 | $8 |
| Hydralazine | 19 | $268 | $14 |
| Nitrostat | 20 | $253 | $13 |
| Metoprolol | 32 | $243 | $8 |
| Pantoprazole | 23 | $243 | $11 |
| Oxybutynin Chloride | 11 | $235 | $21 |
| Prazosin | 11 | $228 | $21 |
| Spironolactone-Hctz | 12 | $224 | $19 |
| Klor-Con 8 | 13 | $211 | $16 |
| Metformin | 18 | $204 | $11 |
| Diltiazem 24hr Cd | 12 | $196 | $16 |
| Benazepril | 23 | $194 | $8 |
| Allopurinol | 11 | $136 | $12 |
| Glimepiride | 12 | $125 | $10 |
| Enalapril Maleate | 14 | $109 | $8 |
| Diltiazem | 11 | $79 | $7 |
| Methimazole | 13 | $78 | $6 |
2013: 40 drugs
| Xarelto | 25 | $13,115 | $525 |
| Diovan | 20 | $7,443 | $372 |
| Metoprolol | 135 | $7,353 | $54 |
| Clonidine | 41 | $6,396 | $156 |
| Atorvastatin | 160 | $5,965 | $37 |
| Clopidogrel | 91 | $2,739 | $30 |
| Carvedilol | 162 | $2,397 | $15 |
| Lovaza | 14 | $1,877 | $134 |
| Warfarin | 132 | $1,875 | $14 |
| Losartan | 91 | $1,608 | $18 |
| Amlodipine Besylate | 115 | $1,595 | $14 |
| Diltiazem 24hr Er | 24 | $1,398 | $58 |
| Potassium Chloride | 44 | $1,337 | $30 |
| Pravastatin | 53 | $1,153 | $22 |
| Losartan-Hydrochlorothiazide | 54 | $1,097 | $20 |
| Lansoprazole | 14 | $1,004 | $72 |
| Digox | 64 | $930 | $15 |
| Isosorbide Mononitrate Er | 48 | $832 | $17 |
| Hydrochlorothiazide | 79 | $813 | $10 |
| Lisinopril | 78 | $784 | $10 |
| Diltiazem Er | 14 | $628 | $45 |
| Furosemide | 108 | $623 | $6 |
| Ramipril | 20 | $598 | $30 |
| Simvastatin | 43 | $530 | $12 |
| Verapamil Er | 11 | $437 | $40 |
| Hydralazine | 27 | $393 | $15 |
| Tamsulosin | 14 | $335 | $24 |
| Metoprolol | 33 | $297 | $9 |
| Pantoprazole | 18 | $262 | $15 |
| Spironolactone | 25 | $255 | $10 |
| Clonidine | 14 | $232 | $17 |
| Omeprazole | 11 | $223 | $20 |
| Spironolactone-Hctz | 12 | $187 | $16 |
| Atenolol | 21 | $185 | $9 |
| Allopurinol | 20 | $178 | $9 |
| Benazepril | 17 | $168 | $10 |
| Enalapril Maleate | 15 | $167 | $11 |
| Hydrocodone-Acetaminophen | 12 | $113 | $9 |
| Diltiazem | 11 | $109 | $10 |
| Methimazole | 13 | $83 | $6 |
Money from drug and device companies
$34 in 2025
| 2025 | 2 | 2 | None | $34 |
| 2024 | 1 | 3 | None | $51 |
| 2022 | 1 | 15 | None | $328 |
| 2021 | 1 | 1 | None | $19 |
| 2019 | 2 | 2 | None | $134 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Cordis US | Mynx Control Venous | $20 | 1 payment
|
| Novo Nordisk | Ozempic | $14 | 1 payment
|
See all 2 published payments
| Cordis US | Meals · 2025-08-15 | Mynx Control Venous | $20 |
| Novo Nordisk | Meals · 2025-01-08 | Ozempic | $14 |
See earlier years (2024, 2022, 2021, 2019)
2024: $51
| Abbott Laboratories | Assurity | $51 | 3 payments
|
2022: $328
| Ironshore Pharmaceuticals | Jornay Pm | $328 | 15 payments
|
2021: $19
| Abbott Laboratories | Pressurewire Ffr | $19 | 1 payment
|
2019: $134
| Abiomed | Impella | $125 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $9 | 1 payment
|
Checkups this office reported
22 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 90.8 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 100%That's most of the people this applied to. | 39 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 82%That's most of the people this applied to. | 966 |
| Bone-density scans that were not neededYounger women who got a bone scan without a medical reason | 0%That's few of the people this applied to. Better on this measure. | 97 |
| Breast cancer screeningEligible women who got a mammogram | 46%That's less than half. | 319 |
| Cervical cancer screeningEligible women who got a Pap or HPV test | 28%That's less than half. | 337 |
| Checked for fall riskOlder patients screened for fall risk | 27%That's less than half. | 971 |
| Closing the Referral Loop: Receipt of Specialist ReportAs Medicare defines this measure | 1% | 395 |
| Colon cancer screeningEligible adults who got a colon cancer test | 30%That's less than half. | 1,088 |
See the other 14 measures
| Coronary Artery Disease (CAD): Beta-Blocker Therapy Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <= 40%)As Medicare defines this measure | 80% | 74 |
| Daily function assessedPatients whose ability to manage daily activities was assessed | 0%That's few of the people this applied to. | 124 |
| Depression screeningPatients screened for depression, with a follow-up plan if needed | 16%That's few of the people this applied to. | 1,885 |
| Diabetes eye examPeople with diabetes who got a retinal eye exam | 2%That's few of the people this applied to. | 282 |
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 46%That's less than half. Better on this measure. | 282 |
| HIV screeningEligible patients who were screened for HIV | 14%That's few of the people this applied to. | 1,120 |
| Medications listed in the chartVisits where the current medication list was documented | 98%That's most of the people this applied to. | 3,687 |
| Oncology: Medical and Radiation - Pain Intensity QuantifiedAs Medicare defines this measure | 8% | 24 |
| Patients can see their records onlinePatients who were given electronic access to their health information | 100%That's most of the people this applied to. | 810 |
| Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper | 98%That's most of the people this applied to. | 1,472 |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 4%That's few of the people this applied to. Better on this measure. | 1,004 |
| Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure | 54% | 1,413 |
| Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin | 92%That's most of the people this applied to. | 1,036 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 77%That's most of the people this applied to. | 1,995 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Care transition standard operational improvements
- Checks the state prescription-drug database before prescribing
- Did a security review of patient data
- Exchanges records both ways with other health systems
- High Priority Practices Guide of the Safety Assurance Factors for EHR Resilience (SAFER) Guides
- ONC-ACB Surveillance Attestation
- Provides care coordination
- Reports cases to public health electronically
- Reports immunizations to the state registry
Professional record
- NPI
- 1245262716
- Licence
- CA A76026California A76026: Current · expires 2027-07-31
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 200 Jose Figueres Ave, Suite 255, San Jose, CA, 95116
- NPI first listed
- 2006-07-07
- NPI last updated
- 2013-06-14
This is when the NPI record was last certified, not a medical board exam.